Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2013
10/31/2013WO2013162905A1 Methods of producing and using regulatory b-cells
10/31/2013WO2013162773A1 Quantitation of biomarkers for the detection of prostate cancer
10/31/2013WO2013162654A1 Methods for detecting allosteric modulators of proteins
10/31/2013WO2013162631A1 Capturing and processing instant drug test results using a mobile device
10/31/2013WO2013162611A1 Sensing of gaseous leakage into body for early detection of colorectal anastomotic leakage
10/31/2013WO2013162502A1 Tissue visualization for resection
10/31/2013WO2013162458A1 Ro52 AS A PREDICTIVE MARKER FOR IMMUNE DERIVED TUMOR OUTCOME
10/31/2013WO2013162456A1 Method for detecting concentration of antibody or fusion protein
10/31/2013WO2013162400A1 Determining physical properties of solid materials suspended in a drilling fluid
10/31/2013WO2013162382A1 Method for detoxification or measurement of at least one compound or at least one fluid in a host body
10/31/2013WO2013162368A1 Biomarkers
10/31/2013WO2013162286A1 Marker for detecting potency of adipose-derived stem cells, and use thereof
10/31/2013WO2013162276A1 Composition for detecting nucleic acid and method for detecting nucleic acid using same
10/31/2013WO2013162175A1 Biochemical assay cartridge
10/31/2013WO2013162133A1 Method for detecting existence of heavy metals in mine soil using changes in expression of mtl-2 gene in caenorhabditis elegans
10/31/2013WO2013162102A1 Biosensor including nanowires functionalized using plasma polymerization and method for manufacturing same
10/31/2013WO2013162100A1 Biomarker composition for diagnosis of periodontal disease
10/31/2013WO2013162064A1 Urokinase-type plasminogen activator transgenic mouse
10/31/2013WO2013162060A1 Method for predicting developmental toxicity while considering in vivo kinetics
10/31/2013WO2013162021A1 Prophylactic or therapeutic agent for hepatic diseases
10/31/2013WO2013161797A1 Blood glucose meter
10/31/2013WO2013161796A1 Blood glucose meter
10/31/2013WO2013161693A1 Diagnostic agent and diagnostic method for irritable bowel syndrome induced by abnormal proliferation of enterobacteria
10/31/2013WO2013161675A1 Method for stabilizing serum or plasma ascorbic acid
10/31/2013WO2013161664A1 Coloration analysis device
10/31/2013WO2013161614A1 Antigen detection method which uses lectin and comprises enzyme treatment step
10/31/2013WO2013161556A1 Blood glucose meter
10/31/2013WO2013161286A1 Handle device and breath analysis device
10/31/2013WO2013161155A1 Image measurement device, image measurement method, and image-measuring program
10/31/2013WO2013160882A1 Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method.
10/31/2013WO2013160836A1 Enhancing surface plasmon resonance imaging signal
10/31/2013WO2013160701A1 Anthracenyl - tetralactam macrocycles and their use in detecting a target saccharide
10/31/2013WO2013160676A1 Antibodies against cd106 (vcam-1)
10/31/2013WO2013160547A1 Method for characterizing and/or determining samples
10/31/2013WO2013160491A1 Tumour biomarker of the affected status of non-sentinel lymph nodes
10/31/2013WO2013160425A1 Improvement of the sensitivity and the dynamic range of photometric assays by generating multiple calibration curves
10/31/2013WO2013160424A1 Multi-application approach for photometric determination of an analyte in a fluid sample on an automated analyzer
10/31/2013WO2013160415A1 Human taste cells capable of continuous proliferation
10/31/2013WO2013160397A1 Quantification of impurities for release testing of peptide products
10/31/2013WO2013160154A1 Maintenance unit
10/31/2013WO2013159939A1 Methods for determining and/or monitoring conditions of a three dimensional cell culture system and optical sensor device for conducting said methods
10/31/2013WO2013159872A1 Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope
10/31/2013WO2013159296A1 Method for marking blood cell reagent or controlling test process
10/31/2013WO2013159227A1 Bitter taste receptor constitutively active mutants
10/31/2013WO2013159211A1 Method for stabilizing quantum-dots
10/31/2013WO2013159204A1 Substances detection system and method
10/31/2013WO2013129655A3 Method for predicting proliferation of microbial count
10/31/2013WO2013128389A3 Water-based wetness-indicating composition and sensor
10/31/2013WO2013124815A3 Mesenchymal stem cells for in vitro modeling and cell-based therapy of human diseases and banks thereof
10/31/2013WO2013121351A3 Oncogenic human cytomegalovirus
10/31/2013WO2013108168A3 Determining a presence of target molecules in a body fluid comprising cells
10/31/2013WO2013090738A9 Device and system for mechanical measurement of biomaterial
10/31/2013WO2013078455A3 Proteomic identification of antibodies
10/31/2013WO2013040212A3 Unique transcriptional signatures in the blood of clinical responders
10/31/2013WO2012145390A9 Cards for sample storage and delivery comprising sintered porous plastic
10/31/2013WO2012006617A9 Optical analyte measurement
10/31/2013WO2003023014A9 Human ion channels
10/31/2013WO2003020910A9 POLYNUCLEOTIDE ENCODING A NOVEL HUMAN POTASSIUM CHANNEL BETA-SUBUNIT, K+betaM8
10/31/2013WO2002059349A9 Odorant receptors and uses thereof
10/31/2013US20130291134 Humanized transgenic mouse model
10/31/2013US20130289869 Electronic pet and pet interaction system thereof
10/31/2013US20130289142 Her3 protein srm/mrm assay
10/31/2013US20130289140 Biological complex specific for alzheimer's disease detection in vitro and use thereof
10/31/2013US20130289139 Diagnostic assay
10/31/2013US20130289121 Pulmonary disease treatment and diagnosis based on arhgef1
10/31/2013US20130289056 Methods of administering an egfr inhibitor
10/31/2013US20130289022 Tetrameric alpha-synuclein and use thereof
10/31/2013US20130288976 Methods for Determining the Presence or Risk of Developing Facioscapulohumeral Dystrophy (FSHD)
10/31/2013US20130288969 Parathyroid hormone receptor activation and stem and progenitor cell expansion
10/31/2013US20130288922 Arrayed detector system for measurement of influenza immune response
10/31/2013US20130288921 Mutated parvovirus structural proteins as vaccines
10/31/2013US20130288920 Multianalyte molecular analysis using application-specific random particle arrays
10/31/2013US20130288914 Method Of Determining Administration Effect In Cancer Chemotherapy With S-1
10/31/2013US20130288912 Biomarker signatures and uses thereof
10/31/2013US20130288908 Polynucleotide construct capable of displaying fab in a cell-free translation system, and method for manufacturing and screening fab using same
10/31/2013US20130288900 Combinatorial libraries of conformationally constrained polypeptide sequences
10/31/2013US20130288390 Immunological assay method
10/31/2013US20130288389 Methods for amplification and detection of prions
10/31/2013US20130288388 Stain-free protein quantification and normalization
10/31/2013US20130288387 Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
10/31/2013US20130288385 Molecularly imprinted tetraethoxysilane polymer and methods of using the same to detect secosteroids
10/31/2013US20130288383 Highly Sensitive System and Method for Analysis of Troponin
10/31/2013US20130288373 Crystal structure of flt3 ligand-receptor complex
10/31/2013US20130288367 Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
10/31/2013US20130288365 Cell Line, System and Method for Optical-Based Screening of Ion-Channel Modulators
10/31/2013US20130288359 Calibratable sensor unit for reaction vessels
10/31/2013US20130288347 Scanning analyzer for single molecule detection and methods of use
10/31/2013US20130288342 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna
10/31/2013US20130288293 Biological Markers for Tracking Distinctive Cellular Events and Uses Thereof
10/31/2013US20130288289 High Throughput Screen
10/31/2013US20130288287 Fibrous structure
10/31/2013US20130288285 Methods for predicting cardiac toxicity
10/31/2013US20130288280 Alzheimer's diagnosis
10/31/2013US20130288279 Specific a1at monoclonal antibodies for detection of endometriosis
10/31/2013US20130288277 Immunoassay of cofilin 1 protein
10/31/2013US20130288276 Method for prediction of prognosis of sepsis
10/31/2013US20130288275 Compositions and methods for detecting acetylated sumo proteins
10/31/2013US20130288274 Recombinant deamidated gliadin antigen
10/31/2013US20130288273 Method for Detecting Cancer Cell
10/31/2013US20130288272 Lung cancer differential marker
1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 3937